Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...

Pharmaceutical Equivalents

Pharmaceutical Equivalents

As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.

Nonlinear Pharmacokinetics: Overview

Nonlinear Pharmacokinetics: Overview

Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Placental hypoxia and oxidative stress responses to smokeless tobacco use in Alaska Native participants in the MAW study.

Canadian journal of physiology and pharmacology·2026

Same author

Practices and implementation factors of point-of-care testing for acute upper respiratory tract infections by community pharmacists in Alberta: A cross-sectional survey.

Journal of the American Pharmacists Association : JAPhA·2025

Same author

An international portrait of pharmacists' professional role identities: A Q-methodology innovative study.

Exploratory research in clinical and social pharmacy·2025

Same author

Prevalence and impact of vasomotor symptoms due to menopause among women in Brazil, Canada, Mexico, and Nordic Europe: a cross-sectional survey: Erratum.

Menopause (New York, N.Y.)·2025

Same author

Menopause in the workplace: does physical activity and sitting time make a difference?

Menopause (New York, N.Y.)·2025

Same author

Prevalence and impact of vasomotor symptoms due to menopause among women in Canada: A subgroup analysis from an international cross-sectional survey of Women with Vasomotor Symptoms Associated with Menopause (WARM Study).

Menopause (New York, N.Y.)·2024

Search research articles

Related Experiment Video

Updated: May 23, 2026

Novel Apparatus and Method for Drug Reinforcement

Novel Apparatus and Method for Drug Reinforcement

Published on: August 20, 2010

University-based continuing education for pharmacists.

Theresa J Schindel¹, James P Kehrer, Nesé Yuksel

¹Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada. tschindel@pharmacy.ualberta.ca

American Journal of Pharmaceutical Education

|March 23, 2012

Summary

University-based continuing education (CE) supports pharmacists' professional development and advances pharmacy practice. Future directions emphasize integrating CE with faculty activities and expanding its reach to meet evolving healthcare needs.

Keywords:

continuing education continuing professional development professional development universities

Related Experiment Videos

Last Updated: May 23, 2026

Novel Apparatus and Method for Drug Reinforcement

Novel Apparatus and Method for Drug Reinforcement

Published on: August 20, 2010

Area of Science:

Pharmacy education
Continuing professional development

Background:

University-based continuing education (CE) is vital for pharmacist professional development and advancing healthcare.
Expanded pharmacy scope of practice necessitates evolving CE approaches.

Purpose of the Study:

To discuss the role and future directions of university-based CE in pharmacy.
To propose strategies for enhancing CE to meet current and future needs of pharmacists.

Main Methods:

This paper presents a perspective from a Faculty of Pharmacy on future CE directions.
It discusses integration of CE with core faculty activities and audience expansion.

Main Results:

Current CE models incorporate diverse approaches, emphasizing the learning process and continuing professional development (CPD).
Future directions include integrating CE with academic activities, broadening audience, and forming strategic partnerships.

Conclusions:

University-based CE is crucial for bridging academic and practice environments.
The Faculty of Pharmacy and Pharmaceutical Sciences advocates for a proactive approach to shaping the future of CE in pharmacy.